2024 Q3FY25 Investor Presentation v2 · page 36 of 39
Includes detailed footnotes regarding share dilution and convertible notes.
Consulting deck · appendix_disclosure · summarize · balanced density
Slide locked Sign in to view
Slide schematic 4/4
disclaimer 1/1 table 1/1 title 2/2
Components 4
disclaimer data headline subtitle
Tools 1
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 0
∅
No frameworks
No framework match is anchored to this slide.